BXP · Q2 2025 Earnings

This is BXP's first brief in Tapebrief coverage, so cross-quarter arc lines will begin next quarter. That said, management itself flagged what changed.

From defensive market commentary to offensive capital allocation. Management spent prior cycles framing 343 Madison and similar projects as contingent — on MTA terms, on pre-leasing thresholds, on financing windows. This quarter the language flipped: "we're proceeding with the project…and plan to immediately commence full vertical construction of the building, which will allow delivery in late 2029." Pairing this with an executed LOI for ~30% of the building at underwritten economics, plus a 1.3M SF proposal pipeline, signals that BXP believes the premier-workplace bid has firmed enough to underwrite a hard-cost commitment of roughly $1.6B (just-under-$2B total development cost including ~$400M of imputed capital carry) without waiting for further pre-leasing comfort. Management quoted a stabilized cash yield on cost of ~7.5%–8%.

Reframing AI from threat to demand driver. A year ago, AI was typically discussed in office REIT calls as a headcount-automation risk. This quarter management put it on the other side of the ledger: "those companies that are industry leaders will be creating AI products, will be using AI products, and we will experience growth in demand from those companies." Combined with the Fortune-100 in-office data point — "Fortune 100 companies that are fully in the office climbed tenfold from 5% to 54%" — management is constructing a thesis where AI economics concentrate intellectual labor in gateway-market premier buildings. This is the analytical spine of the bullish posture.

Capital markets are unfrozen. Management cited Q2 office sales volume of $14.2B, up 80% QoQ and 125% YoY, with financing increasingly available at tightening spreads for higher-quality assets. This is no longer a "we're patient" call — it's a "the window is opening" call, which is why the 343 Madison commitment, the asset sale program, and the leverage moderation framework all landed together this quarter.

Leverage trajectory shifts from "elevated indefinitely" to a path back to the target range. Management laid out a specific deleveraging mechanism: 290 Binney delivery, occupancy gains, and asset sales bringing leverage back into the mid-six to mid-seven turn range. The asset sale plan has two distinct buckets: ~$300M from 10 non-income-producing assets (land sites and largely empty buildings) over the next two years, plus another ~$300M from income-producing properties more likely to close in 2026 than 2025. Management said the aggregate program is not expected to be dilutive to FFO "because of the significant portion of non-income producing assets" — implying the income-producing piece on its own could carry some dilution.

Residual hedges remain. Management was careful on lab/life-science ("demand light"), the West Coast ("return-to-office lags East Coast"), and NYC political risk ("mayoral election…could bring non-constructive CRE policies"). The bullishness is selective, not blanket.